Home › Peptides

GLP-1 Side Effects: What Research Reports

By the Strength from the Well Editorial Team · Evidence last reviewed September 2026 · Not reviewed by a licensed clinician (why we say that)

The short answer

The most common side effects of GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, and constipation, reported by a large share of participants in clinical trials and usually worst in the first weeks and after each dose increase. Less common but serious risks on the approved labels include pancreatitis, gallbladder disease, severe slowing or obstruction of the gut, kidney injury from dehydration, and low blood sugar when combined with insulin or certain diabetes pills. The class also carries a boxed warning based on thyroid tumors in rodents, which makes these drugs off-limits for people with certain personal or family cancer histories.

Key points

Gastrointestinal effects are the main reason people stop, and they tend to be worst early and after dose increases.
Most GI side effects ease over weeks; a minority do not, and that is a legitimate reason to change course.
Serious but less common risks include pancreatitis, gallbladder problems, bowel obstruction, and dehydration-related kidney injury.
A boxed warning about rodent thyroid tumors makes these drugs contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
Some of the weight lost is muscle, which is why protein intake and resistance training matter during treatment.
Anesthesia teams need to know you take one, because slowed stomach emptying affects sedation safety.

Why the side effects look the way they do

Almost everything on this list follows from what the drug does. GLP-1 slows stomach emptying, changes gut motility, and reduces appetite through the brain. Those are the therapeutic effects. Push them harder than a given person's system tolerates and they become nausea, vomiting, reflux, and constipation.

That framing is useful because it explains the pattern people actually experience. Symptoms cluster in the first weeks and again after each increase in dose, then usually settle as the body adjusts. It also explains why going up slowly, and stopping at the lowest amount that works for you, is the standard approach rather than racing to the highest available dose.

The common ones

In the large weight-management trials, nausea was the most frequently reported side effect, affecting roughly four in ten participants at some point, compared with a much smaller share on placebo. Diarrhea, vomiting, and constipation were each reported by a substantial minority. Most cases were rated mild to moderate and most improved with time, but a meaningful number of people discontinued because of them.

Other common effects include abdominal pain, indigestion, burping with an unpleasant taste, bloating, fatigue, headache, dizziness, and reactions at the injection site. Hair thinning has been reported and is generally attributed to rapid weight loss rather than to the drug itself, which is the same phenomenon seen after other kinds of substantial weight loss.

These are also the effects most amenable to practical management: smaller portions, stopping at the first sense of fullness, going easy on fried and very fatty foods, keeping fluids up, and paying attention to fiber for constipation. If the symptoms are severe enough to keep you from eating or drinking normally, that is not something to power through quietly. Tell your prescriber, because the pace of dose increases is adjustable.

The serious ones on the label

These are less common, and they are the reason ongoing contact with a clinician matters.

Pancreatitis: inflammation of the pancreas, typically felt as severe, persistent upper abdominal pain that may radiate to the back, often with vomiting. It requires immediate evaluation.
Gallbladder disease: gallstones and inflammation, more common with rapid weight loss generally. Pain in the right upper abdomen, especially after meals, plus fever or yellowing of the skin or eyes, needs prompt attention.
Slowed gut motility and ileus: reports of severe gastroparesis and intestinal obstruction have led to label updates. Persistent vomiting, inability to pass stool or gas, and a swollen abdomen are warning signs.
Kidney injury: usually a consequence of dehydration from vomiting or diarrhea rather than a direct effect on the kidney, but it can be serious and it is preventable by staying ahead of fluid losses.
Low blood sugar: not typical from these drugs alone, but a real risk when combined with insulin or sulfonylureas, which often need to be adjusted.
Allergic reactions: rash, swelling of the face or throat, or difficulty breathing require emergency care.
Diabetic retinopathy complications: a signal seen in one large semaglutide trial in people with type 2 diabetes, thought to relate to rapid improvement in blood sugar. People with existing retinopathy should have eye follow-up planned.
Thyroid C-cell tumors: seen in rodents, unknown relevance to humans, but the basis for the boxed warning and the contraindication for people with a personal or family history of medullary thyroid carcinoma or MEN 2.

Anesthesia, procedures, and pregnancy

Because these drugs slow stomach emptying, food can remain in the stomach longer than expected, which raises the risk of aspiration during sedation. Anesthesia organizations have issued guidance on how to handle this, and the practical requirement for you is simple: tell every surgeon, dentist, endoscopist, and anesthesia provider that you take a GLP-1 medication, and name it. Do not assume it is in the chart.

These medications are not recommended during pregnancy, and animal studies have shown harm to offspring. Anyone who could become pregnant should discuss contraception and a plan for stopping before conception, including the fact that some of these drugs take weeks to clear.

If you have a history of pancreatitis, gastroparesis, inflammatory bowel disease, an eating disorder, or significant gallbladder disease, say so before starting, not after a problem develops.

Muscle, bone, and what the scale does not show

Any substantial weight loss, by any method, includes loss of lean tissue along with fat. Body composition studies in GLP-1 trials have found that a meaningful fraction of the weight lost is lean mass, in a range broadly similar to other approaches that produce comparable weight loss.

This matters most for older adults and for anyone whose strength and balance are already marginal, because muscle is what keeps you out of a nursing home later. The response is not to avoid treatment; it is to protect muscle deliberately: adequate protein at every meal even when appetite is low, and resistance training at least twice a week. Eating far less without attending to protein is the version of this that goes badly.

Bone density is a related concern during rapid weight loss and is worth discussing if you have risk factors.

The uncertain territory

A few questions do not yet have settled answers, and it is better to say so.

Mental health has been the most publicized. After reports of suicidal thoughts in people taking these medications, regulators in the US and Europe reviewed the available data and did not find evidence establishing that the drugs cause them. That is not the same as ruling it out, and surveillance continues. If your mood changes on any medication, that is worth reporting promptly rather than dismissing.

Long-term effects are genuinely unknown past the length of the trials, which for most of these drugs means a few years rather than a few decades. The cardiovascular outcome data is reassuring as far as it goes. Beyond that horizon, nobody knows, and anyone who tells you otherwise is guessing.

Rare events are hard to detect in trials by definition, which is why post-marketing reporting exists and why labels continue to change as real-world data accumulates. If you have an unexpected reaction, reporting it to your clinician and to the FDA's adverse event program is how that system learns.

When to call someone

Contact your clinician promptly for: vomiting or diarrhea you cannot control or that prevents you from keeping fluids down; severe or persistent abdominal pain, especially if it goes through to your back; no bowel movement or passing of gas along with a swollen belly; signs of gallbladder trouble including right upper abdominal pain, fever, or yellowing of the skin or eyes; symptoms of low blood sugar such as shakiness, sweating, and confusion; new vision changes; a lump in the neck, hoarseness, or trouble swallowing; and any swelling of the face or throat or difficulty breathing, which means emergency care now.

Do not stop or change a prescribed medication on your own based on something you read at midnight, including this. Write your symptoms down with dates, and call. Being the person who reports things early is not being difficult. It is the part of your care that only you can do.

Common questions

How long do GLP-1 side effects last?

For most people the gastrointestinal effects are worst in the first weeks and after each dose increase, then ease over several weeks as the body adapts. A minority have symptoms that persist, and that is a legitimate reason to revisit the dose or the medication with a prescriber.

Is 'Ozempic face' a real side effect?

The hollowed look people describe is a consequence of losing fat, including facial fat, relatively quickly. It is not a specific action of the drug and it happens with comparable weight loss from any cause. Slower loss and preserving muscle mass tend to make it less pronounced.

Can GLP-1 medications cause pancreatitis?

Pancreatitis appears on the labels as a reported risk and the drugs are used cautiously in people with a history of it. Large trials have not settled whether the class meaningfully increases the rate, but the symptoms are distinctive enough that any severe, persistent upper abdominal pain should be evaluated urgently.

Do side effects mean the medication is working?

No. Nausea is not a marker of effectiveness, and some people lose substantial weight with few symptoms while others feel awful and respond modestly. Tolerating misery is not evidence of progress and should not be treated as a goal.

Will side effects come back if I restart after a break?

Often yes, because tolerance to the gastrointestinal effects builds over time and fades when you stop. Restarting is typically approached the same way as starting, and that should be planned with a prescriber rather than by resuming where you left off.

Sources

This is information, not medical advice. Strength from the Well is an independent publisher. Nothing here is a diagnosis, a prescription, or a recommendation to start or stop any treatment. Talk to a clinician who knows your history before you act on anything you read here — including anything you read here that contradicts them.